Aervent® 0.2 µm, Opticap® XL Capsule

Description

• General description: Device Configuration: Capsule
• Features and Benefits: Rated for aerosol retention of a total challenge of 108–1010 plaque forming units of ΦX-174 virus particles at 85 Nm3/h (50 SCFM) per cartridge.
• Packaging: Double Easy-Open bag
• Quality: Retains Brevundimonas diminuta liquid aerosol for 21 days at a minimum challenge of 10⁷ CFU/cm²
• Preparation Note: Sterilization Method30 autoclave cycles of 30 min @ 135 °C
• Analysis Note: Bacterial RetentionSamples were quantitatively retentive of a minimum Brevundimonas diminuta challenge concentration of 1 x 10⁷ CFU/cm² using ASTM® F838 methodology.
• Other Notes: Directions for UseOrganism Retention: MicroorganismMode of Action: Filtration (size exclusion)Application: BioProcessingIntended Use: Reduction or removal of microorganism/bioburdenInstructions for Use: Please refer Steam Sterilization & Integrity Testing Procedures guide and first page of Visual Inspection GuideStorage Statement: Store in dry locationDisposal Statement: Dispose of in accordance with applicable federal, state and local regulations.
• Legal Information: AERVENT is a registered trademark of Merck KGaA, Darmstadt, Germany
• Disclaimer: EMD Millipore Corporation certifies that this product complies with the European Pressure Equipment Directive, 2014/68/EU of 15 May 2014. This product has been classified under Article 4 § 3 of the Directive 2014/68/EU. It has been designed and manufactured in accordance with sound engineering practice to ensure safe use. In compliance with Article 4 § 3 of the Directive 2014/68/EU, this product does not bear the CE mark.